| 7.22 0.09 (1.26%) | 07-30 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 9.18 | 1-year : | 9.86 |
| Resists | First : | 7.86 | Second : | 8.44 |
| Pivot price | 7.51 |
|||
| Supports | First : | 6.9 | Second : | 5.74 |
| MAs | MA(5) : | 7.5 |
MA(20) : | 7.45  |
| MA(100) : | 6.96 |
MA(250) : | 6.86 |
|
| MACD | MACD : | 0 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 16.9 |
D(3) : | 34.8 |
| RSI | RSI(14): 46.2 |
|||
| 52-week | High : | 8.47 | Low : | 5.38 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ UG ] has closed above bottom band by 26.9%. Bollinger Bands are 130.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 7.28 - 7.32 | 7.32 - 7.36 |
| Low: | 6.9 - 6.96 | 6.96 - 7 |
| Close: | 7.14 - 7.22 | 7.22 - 7.29 |
United-Guardian, Inc., operating both domestically and globally, specializes in the development, production, and distribution of a diverse range of cosmetic raw materials, pharmaceutical solutions, medical-grade lubricants, and proprietary industrial chemicals. Its extensive cosmetic ingredients catalog includes the LUBRAJEL line of water-based moisturizing and lubricating gel formulations, featuring variants such as LUBRAJEL NATURAL (derived from natural sources), LUBRAJEL MARINE, and LUBRASIL II SB (a silicone-infused LUBRAJEL formulation). Other key offerings in this category are LUBRAJEL II XD; B-122, a powdered lubricant suitable for pressed powders, eyeliners, blushes, and industrial uses; KLENSOFT, a surfactant for shampoos, shower gels, and makeup removers; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, and cleansers. For medical applications, United-Guardian provides lubricants like LUBRAJEL RR and RC, which are water-based gels specifically designed for urinary catheters. LUBRAJEL MG serves to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices. The company also offers LUBRAJEL LC and LUBRAJEL FA, specialized LUBRAJEL formulations tailored for oral care, alongside LUBRAJEL FLUID for lubricating various water-soluble products. The pharmaceutical portfolio features RENACIDIN, a prescription medication for preventing and dissolving calcifications in urethral catheters and the urinary bladder. Also included is CLORPACTIN WCS-90, an antimicrobial agent effective against infections in the urinary bladder, localized peritoneal infections, and infections affecting the eyes, ears, nose, throat, and sinuses. Industrial products comprise DESELEX, a sequestering and chelating agent vital for detergent manufacturing, and THOROCLENS, a powerful chlorine-based industrial cleaning solution. The firm also dedicates resources to research and development, primarily focusing on advancing cosmetic ingredients. Products are brought to market through a robust network of marketing partners, distributors, and wholesalers. Established in 1942, United-Guardian maintains its headquarters in Hauppauge, New York.
Wed, 29 Jul 2026
UG|United-Guardian Inc|Price:7.390|Chg%:-0.810 - TradingKey
Tue, 28 Jul 2026
United-Guardian Inc (UG) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Tue, 28 Jul 2026
UG|United-Guardian Inc|Price:7.090|Chg%:-0.240 - TradingKey
Mon, 27 Jul 2026
United-Guardian Inc (UG) Cash Flow - TradingKey
Mon, 27 Jul 2026
UG|United-Guardian Inc|Price:7.090|Chg%:-0.240 - TradingKey
Sun, 26 Jul 2026
United-Guardian, Inc. Revenue Breakdown – NASDAQ:UG - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Consumer Defensive
|
|
|
Industry:
Household & Personal Products
|
|
| Shares Out | 5 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 35.8 (%) |
| Held by Institutions | 20.7 (%) |
| Shares Short | 9 (K) |
| Shares Short P.Month | 7 (K) |
| EPS | 0.51 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.36 |
| Profit Margin | 21.6 % |
| Operating Margin | 22.3 % |
| Return on Assets (ttm) | 11.1 % |
| Return on Equity (ttm) | 21.7 % |
| Qtrly Rev. Growth | 15.8 % |
| Gross Profit (p.s.) | 1.13 |
| Sales Per Share | 2.38 |
| EBITDA (p.s.) | 0.52 |
| Qtrly Earnings Growth | 46 % |
| Operating Cash Flow | 2 (M) |
| Levered Free Cash Flow | 1 (M) |
| PE Ratio | 13.88 |
| PEG Ratio | 1.1 |
| Price to Book value | 3.04 |
| Price to Sales | 3.02 |
| Price to Cash Flow | 14.72 |
| Dividend | 0.25 |
| Forward Dividend | 0 |
| Dividend Yield | 3.4% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|